Month: September 2024

Hemisphere Energy (HMENF) – Hemisphere Provides an Operational Update and Declares a Special Dividend

Posted on by cpereira@noblefcm.com


Thursday, September 26, 2024

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Operational update. Hemisphere has drilled six horizontal wells into its southeast Alberta Atlee Buffalo F and G pools over the past two months, with two wells left to drill as part of its summer program. Drilling operations are expected to be completed early in the fourth quarter with wells put into production as they are tied-in through the remainder of the year. Hemisphere has also commenced polymer injection at its new pilot enhanced oil recovery project in Marsden, Saskatchewan. Management anticipates that it could take until mid-2025 to increase reservoir pressure and to evaluate the production response at the three producers.

Updating estimates. Crude oil prices have weakened since our last update. We have lowered our 2024 adjusted funds flow (AFF) and earnings per share (EPS) estimates to C$43.8 million and C$0.31, respectively, from C$45.4 million and C$0.35. Our third and fourth quarter EPS estimates were lowered by C$0.02 each to C$0.08 and C$0.06, respectively, based on average per barrel WTI crude oil prices of $75.69 and $71.20. While futures prices suggest 2025 WTI pricing in the $68 to $70 per barrel range, we are leaving our 2025 estimates unchanged for now based on a WTI crude oil price of $74.95 per barrel.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Great Lakes Dredge & Dock (GLDD) – Noble Conference Presentation

Posted on by cpereira@noblefcm.com


Thursday, September 26, 2024

Great Lakes Dredge & Dock Corporation is the largest provider of dredging services in the United States. In addition, Great Lakes is fully engaged in expanding its core business into the rapidly developing offshore wind energy industry. The Company has a long history of performing significant international projects. The Company employs experienced civil, ocean and mechanical engineering staff in its estimating, production and project management functions. In its over 131-year history, the Company has never failed to complete a marine project. Great Lakes owns and operates the largest and most diverse fleet in the U.S. dredging industry, comprised of approximately 200 specialized vessels. Great Lakes has a disciplined training program for engineers that ensures experienced-based performance as they advance through Company operations. The Company’s Incident-and Injury-Free® (IIF®) safety management program is integrated into all aspects of the Company’s culture. The Company’s commitment to the IIF® culture promotes a work environment where employee safety is paramount.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Noble Conference. We hosted Great Lakes CFO Scott Kornblau at our Basic Industries Virtual Investor Conference. Mr. Kornblau touched on the Company’s recent strong operating performance, backlog, positive future opportunity, the ship building program, and capital structure. A replay of the presentation, including Q&A can be viewed at: https://www.channelchek.com/videos/great-lakes-dredge-dock-company-gldd-noble-capital-markets-basic-industries-virtual-conference-replay

Operating Performance. Great Lakes has completed three successful quarters in a row and the Company believes the strong operating outlook will continue for the foreseeable future, driven by record budgets at the U.S. Army Corps, supplemental funding for hurricane impacted areas now being released, and other additional funding for large projects expected in the second half of the decade.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

AZZ Inc. (AZZ) – Highlights from the Noble Virtual Basic Industries Equity Conference.

Posted on by cpereira@noblefcm.com


Thursday, September 26, 2024

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New manufacturing facility is on schedule and on budget. AZZ Inc. participated in Noble’s Virtual Basic Industries Conference on September 25. AZZ is the leading independent provider of hot-dip galvanizing and coil coating solutions to a broad range of end markets. With AZZ Precoat Metals’ new manufacturing facility in Washington, Missouri expected to be completed in fiscal year 2025, we expect the facility to contribute to top-line growth in fiscal year 2026 while capital expenditures decline. Approximately 75% of the facility’s production is already committed that we estimate could generate approximately $50 million to $60 million in revenue. A link to the presentation replay is here.

Declining debt balance and cost of capital. Based on the company’s strong first quarter fiscal year 2025 results and outlook, we have assumed AZZ will pay down $90 million of debt this fiscal year, or at the high end of the guidance range. On September 24, AZZ executed a fourth amendment to its existing credit agreement and reduced the interest rate of the Term Loan B by 75 basis points to the Adjusted Term Secured Overnight Financing Rate (SOFR) plus 250 basis points.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Gevo Acquires CultivateAI to Strengthen Verity’s Carbon Accounting Solutions

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Gevo acquires CultivateAI for $6 million to boost Verity’s carbon tracking capabilities.
– The acquisition will accelerate revenue growth and provide advanced agricultural analytics.
– CultivateAI’s SaaS platform integrates real-time agricultural data, driving sustainability and profitability for farmers.

Gevo, Inc. (NASDAQ: GEVO), a renewable energy and carbon solutions company, has announced the acquisition of Cultivate Agricultural Intelligence, LLC (“CultivateAI”) for $6 million in cash. This strategic acquisition will bolster Gevo’s Verity business unit, accelerating the development of Verity’s carbon tracking capabilities, while integrating new revenue streams from CultivateAI’s agricultural data and analytics platform.

CultivateAI, a cloud-based software as a service (SaaS) platform, provides agricultural operators with real-time analytics, helping them make data-driven decisions to improve productivity, sustainability, and profitability. With expected 2024 revenue of $1.7 million and positive cash flow, CultivateAI is already a proven business. Gevo aims to leverage this platform to strengthen Verity’s carbon accounting and tracking solutions, focusing on carbon abatement across sectors like food, feed, fuels, and industrial markets.

Dr. Paul Bloom, Head of Verity and Chief Carbon Officer of Gevo, expressed excitement about the acquisition: “Adding CultivateAI and its inventive approach to Verity will help us grow revenue by providing the most complete set of data-driven analytics services to farmers, agronomists, and researchers. This acquisition accelerates our ability to deliver value to our customers.”

Verity’s primary focus is creating an innovative platform that tracks, verifies, and empirically values carbon intensity throughout the entire carbon lifecycle. With the addition of CultivateAI’s tools and customer base, Verity will extend its reach beyond biofuels and tap into new revenue streams. This integration is poised to strengthen Gevo’s role in promoting sustainability and profitability, particularly for farmers and agricultural service providers.

Gevo’s CEO, Dr. Pat Gruber, emphasized the broader implications of the acquisition: “We are constantly looking for development opportunities that bring new revenue streams to the company. As Verity accelerates, we expect to see more customer relationships and growth opportunities, supporting our mission to build a circular economy.”

CultivateAI’s advanced platform, with its real-time data capabilities, will allow Verity to offer the highest quality carbon abatement solutions while helping clients understand their operations better. The SaaS platform enables farm operators, agronomists, and researchers to access timely, reliable insights, enhancing their ability to manage resources efficiently and sustainably.

Gevo is committed to converting renewable energy and biogenic carbon into sustainable fuels and chemicals with a net-zero or better carbon footprint. With this acquisition, the company takes another step toward its mission of fostering a sustainable, circular economy while driving shareholder value through scalable revenue growth.

As Verity continues to expand its platform, the integration of CultivateAI will not only help improve agricultural operations but will also support the carbon footprint reduction efforts in various industries. By offering clients innovative, data-driven solutions, Gevo aims to lead the way in sustainability-focused business practices.

Mortgage Refinance Boom Takes Hold as Weekly Demand Surges 20%

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Refinancing applications surged 20% in one week amid declining mortgage rates.
– Mortgage rates fell to 6.13%, the lowest in two years, driving demand.
– The refinance share of mortgage applications reached 55.7% of total demand.

Mortgage refinance activity has seen a significant surge as homeowners across the United States rush to take advantage of falling interest rates. According to the Mortgage Bankers Association (MBA), applications to refinance home loans soared by 20% last week compared to the previous week, driven by the continuous decline in mortgage rates. This marks a stunning 175% increase in refinance demand from the same time last year.

The average contract interest rate for 30-year fixed-rate mortgages with conforming loan balances ($766,550 or less) dropped to 6.13% from 6.15%. Though the change may seem small, the cumulative effect of eight straight weeks of declining rates is pushing homeowners to seize the opportunity for potential savings. Joel Kan, vice president and deputy chief economist at MBA, highlighted this ongoing trend: “The 30-year fixed rate decreased for the eighth straight week to 6.13%, while the FHA rate decreased to 5.99%, breaking the psychologically important 6% level.”

Refinance applications now make up 55.7% of all mortgage applications, showcasing how appealing the current rates are for homeowners. However, while the percentage rise is significant, the overall level of refinancing activity remains modest when compared to previous refinancing waves. The ongoing economic environment, combined with seasonal slowdowns in homebuying, has contributed to this pattern.

Despite the seasonal slowdown, mortgage applications to purchase homes rose just 1% over the last week, demonstrating that homebuyers are still facing challenges like high home prices and limited inventory. These factors have kept the pace of new home purchases relatively stable, with purchase applications only 2% higher than the same week last year.

One interesting takeaway from the latest data is that average loan sizes for both refinancing and home purchases have reached record highs. The overall average loan size hit $413,100 last week, the largest in the survey’s history. This reflects both the continued rise in home values and the larger loan amounts that homeowners are seeking, particularly in high-cost markets.

Looking ahead, mortgage rates have not seen significant movement at the start of this week. However, they may react as more pressing economic data, such as jobs reports and inflation numbers, are released in the coming weeks. Any developments in the broader economic outlook could influence the future path of mortgage rates, either stabilizing them or prompting further fluctuations.

For now, homeowners who have yet to take advantage of the current low rates are eyeing the market closely, as more savings could be realized with additional rate cuts. With mortgage rates remaining near their lowest levels in two years, the refinancing boom may continue to gain traction, especially if the Federal Reserve implements further rate cuts to counter slowing economic growth.

Gold Nears Record High as US Data Suggest Further Rate Cuts

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Gold trades near its record high, driven by weak US economic data and rising rate cut expectations.
– Gold has surged 29% this year, with silver also gaining 34%, supported by Fed rate cuts and strong central bank purchases.
– Investors anticipate further gains in precious metals due to geopolitical tensions and US monetary policy shifts.

Gold prices are trading near record highs as weak US economic data strengthens the case for further interest rate cuts by the Federal Reserve. On Wednesday, bullion reached a peak of $2,670.57 an ounce before stabilizing at $2,657.73, reflecting a 29% rise this year. Silver has also seen substantial gains, increasing by 34% since January.

The recent spike in gold prices follows a report indicating a sharp decline in US consumer confidence, marking the largest drop in three years. This data has led swaps traders to increase bets on deeper cuts, expecting the Federal Reserve to lower rates by three-quarters of a point by the end of the year. Lower interest rates typically boost demand for gold, which doesn’t generate interest or dividends, making it an attractive asset in a low-rate environment. The rate cuts have also weakened the US dollar, further supporting gold by making it cheaper for international buyers.

Silver, often trading in tandem with gold, is benefitting from its dual role as both a precious metal and an industrial commodity. Its use in clean-energy technologies, such as solar panels, gives it additional exposure to the global economic cycle. As a result, silver prices have closely followed gold’s upward trajectory. Analysts from Standard Chartered and UBS expect silver to continue outperforming in the current market conditions, given the rising demand for industrial metals driven by global clean energy initiatives and the broader economic recovery.

Geopolitical tensions are also bolstering the demand for gold, with the precious metal seen as a safe-haven asset in uncertain times. With less than six weeks until the US presidential election, the financial markets are bracing for potential volatility. Political uncertainty, coupled with a broader global economic slowdown, has fueled a rush toward assets like gold and silver, which are considered more stable in times of turmoil.

Looking ahead, major banks, including J.P. Morgan, UBS, and Goldman Sachs, predict that gold’s upward trend will persist into 2025. Many of these forecasts are based on continued inflows into gold-backed exchange-traded funds (ETFs) and the expectation of further interest rate cuts by central banks around the world. For instance, J.P. Morgan anticipates that gold could reach $2,775 per ounce by next year, with a potential spike toward $3,000 in 2025. These bullish forecasts reflect a broader market sentiment that gold’s rally is far from over, particularly as the Federal Reserve continues its easing cycle to counter economic slowdowns.

While gold and silver investors are enjoying the current market rally, other sectors, particularly industrial metals, have also seen benefits. Beijing’s announcement of stimulus measures aimed at reviving China’s economy has led to increased demand for metals used in construction and technology, further supporting the price of silver. As these global economic trends continue to unfold, investors will keep a close eye on additional US data, such as the personal consumption expenditures gauge and jobless claims, to gauge the Federal Reserve’s next move.

Release – Lifeway Foods Confirms Receipt of Unsolicited, Non-Binding Proposal from Danone

Posted on by dburczyk@noblecapitalmarkets.com

Research News and Market Data on LWAY

MORTON GROVE, Ill., Sept. 24, 2024 /PRNewswire/ — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, confirmed that it has received an unsolicited, non-binding proposal from Danone North America PBC (“Danone”) to acquire all outstanding shares of common stock of Lifeway it does not already own for $25.00 per share in cash. According to the Schedule 13D amendment filed yesterday with the U.S. Securities and Exchange Commission disclosing the proposal, Danone beneficially owns approximately 23.4% of Lifeway’s outstanding common stock.

Consistent with its fiduciary duties, Lifeway’s board of directors, in consultation with its independent outside advisors, will carefully review and evaluate the proposal to determine the course of action that it believes is in the best interests of the Company and its stakeholders. 

The Company does not undertake any obligation to provide any updates with respect to this or any other proposal or transaction, except as required under applicable law.

Lifeway shareholders do not need to take any action at this time. 

About Lifeway Foods, Inc.

Lifeway Foods, Inc., which has been recognized as one of Forbes’ Best Small Companies, is America’s leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway’s tart and tangy fermented dairy products are now sold across the United States, Mexico, Ireland, South Africa and France. Learn how Lifeway is good for more than just you at lifewayfoods.com.

Contacts:

Derek Miller
Vice President of Communications, Lifeway Foods
Email: derekm@lifeway.net 

OR

Longacre Square Partners
Joe Germani / Miller Winston
Email: LWAY@longacresquare.com

Forward-Looking Statements

This release (and oral statements made regarding the subjects of this release) contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position, business strategy and objectives. These statements use words, and variations of words, such as “continue,” “build,” “future,” “increase,” “drive,” “believe,” “look,” “ahead,” “confident,” “deliver,” “outlook,” “expect,” and “predict.” Other examples of forward-looking statements may include, but are not limited to, (i) statements of Company plans and objectives, including the introduction of new products, or estimates or predictions of actions by customers or suppliers, (ii) statements of future economic performance, and (III) statements of assumptions underlying other statements and statements about Lifeway or its business. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway’s expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and the Company’s subsequent filings with the SEC. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Information in this release is as of the dates and time periods indicated herein, and Lifeway does not undertake to update any of the information contained in these materials, except as required by law. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED PRESS RELEASE

Euroseas (ESEA) – Favorable Time Charter Contract for the M/V Synergy Busan

Posted on by cpereira@noblefcm.com


Wednesday, September 25, 2024

Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA. Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New time charter contract. Euroseas Ltd. executed a time charter contract for M/V Synergy Busan at a gross daily rate of $35,500 for a minimum period of 36 to a maximum period of 38 months at the option of the charterer. The M/V Synergy Busan is 4,250 TEU intermediate container ship. Recall that TEU is a unit of cargo capacity that is based on the volume of a twenty-foot-long intermodal container that can be transferred between different carriers. The new charter will commence in early December 2024 in continuation of its existing charter.

Favorable rate and improved charter coverage. The new time charter is a significant improvement over the previous contracted rate of $25,000 per day and is expected to contribute EBITDA of ~$29 million during the minimum contracted period. Recall that Euroseas installed energy saving devices on the M/V Synergy Busan during the ship’s drydock last year which likely factored into the higher charter rate. The new time charter improves Euroseas’ remaining 2024 and 2025 charter coverage to 95% and ~50%, respectively. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

China’s E-commerce Giants Surge After Stimulus Package Boost

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Alibaba, JD.com, and Pinduoduo stocks soar after China announces new monetary stimulus measures.
– The People’s Bank of China released $140 billion in liquidity by cutting interest rates and reserve requirements.
– Skepticism remains over whether these measures will lead to long-term economic recovery.

China’s major e-commerce players—Alibaba, JD.com, and Pinduoduo—saw a significant stock surge on Tuesday after the People’s Bank of China (PBOC) unveiled its first major stimulus package since the pandemic. The central bank’s efforts aim to inject liquidity into the economy and spark growth amid ongoing challenges in the property market and reduced consumer demand.

Shares of Alibaba rose by 7%, while JD.com jumped 11%, and Pinduoduo saw an increase of nearly 10%. This sharp rise followed the PBOC’s announcement of key interest rate cuts and a reduction in reserve requirements for banks. These measures are expected to free up around 1 trillion yuan ($140 billion) in liquidity, making it easier for businesses and households to access loans at lower interest rates.

The stimulus comes at a critical time for China’s economy, which has been grappling with a cooling property market and weaker-than-expected demand in recent months. The government’s regulatory crackdown on tech companies over the last few years further compounded the struggles of companies like Alibaba and JD.com. At the height of this crackdown, Alibaba was slapped with a $2.6 billion fine for antitrust violations. Despite some recovery in 2024, these companies remain far from their 2020 stock price highs.

The tech sector, which includes major firms such as Baidu, Tencent, and NetEase, saw a broad rally following the announcement. The CSI 300, Shanghai Composite, and Hang Seng indexes all rose over 4%, reflecting optimism among investors about the new economic measures.

While the stock market responded favorably, some experts remain cautious about the long-term impact of China’s stimulus efforts. Charles Schwab’s chief global investment strategist, Jeffrey Kleintop, expressed doubts that these moves will be enough to stabilize China’s property market or significantly improve household incomes. “A lower mortgage rate on existing loans might help households, but it doesn’t do anything to arrest the decline in property prices or aggregate incomes or jobs,” said Kleintop. Wolfe Research chief economist Stephanie Roth echoed these sentiments, noting that similar announcements in the past have generated excitement but did not produce sustained economic improvements.

The stakes are high for China’s economy, which has long been seen as a key driver of global growth. As the world’s second-largest economy, a slowdown in China could have ripple effects across international markets. Investors are keenly watching whether these new stimulus measures will generate enough momentum to help China regain its footing and whether companies like Alibaba and JD.com can continue to capitalize on a more favorable economic environment.

Despite the skepticism, the stock surge offers a brief respite for Chinese e-commerce firms, which have faced intense pressure over the last few years. While these gains are encouraging, the question remains whether this upward trajectory will last or if more comprehensive measures will be needed to keep China’s economic recovery on track.

Release – Hemisphere Energy Declares Special Dividend and Provides Operations Update

Posted on by dburczyk@noblecapitalmarkets.com

Research News and Market Data on HMENF

Vancouver, British Columbia–(Newsfile Corp. – September 24, 2024) – Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) (“Hemisphere” or the “Company”) is pleased to announce that its board of directors has approved the declaration of a special dividend to shareholders and provide an update from field operations.

Special Dividend

Given the strong financial position and performance outlook of the Company, Hemisphere is pleased to announce that its board of directors has approved the declaration of a special dividend of C$0.03 per common share, in accordance with its dividend policy. The special dividend will be paid on October 25, 2024 to shareholders of record on October 11, 2024, and is designated as an eligible dividend for Canadian income tax purposes. It is in addition to the Company’s quarterly base dividend of C$0.025 per common share.

Hemisphere has committed $17.4 million to shareholder returns to date in 2024, including quarterly base dividend payments in February, June, and September, special dividend payments in July and October, and shares repurchased and cancelled under the Company’s normal course issuer bid. This return of capital is funded entirely by the Company’s free cash flow, and is made possible by its high netback, ultra-low decline enhanced oil recovery (“EOR”) assets.

Operations Update

The Company has drilled six successful horizontal wells into its southeast Alberta Atlee Buffalo F and G pools over the past two months, with two remaining wells to drill as part of its summer development program. Drilling operations are expected to be finished early in the fourth quarter, and wells brought on production as they are tied-in through the remainder of the year.

Hemisphere has also commenced polymer injection at its new pilot EOR project in Marsden, Saskatchewan. Management anticipates that it could take until mid-2025 to increase reservoir pressure and evaluate production response at the three producers.

About Hemisphere Energy Corporation

Hemisphere is a dividend-paying Canadian oil company focused on maximizing value per share growth with the sustainable development of its high netback, ultra-low decline conventional heavy oil assets through polymer flood EOR methods. Hemisphere trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “HME” and on the OTCQX Venture Marketplace under the symbol “HMENF”.

For further information, please visit the Company’s website at www.hemisphereenergy.ca to view its corporate presentation or contact:

Don Simmons, President & Chief Executive Officer
Telephone: (604) 685-9255
Email: info@hemisphereenergy.ca

Website: www.hemisphereenergy.ca

Forward-looking Statements

Certain statements included in this news release constitute forward-looking statements or forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “anticipate”, “continue”, “estimate”, “expect”, “forecast”, “may”, “will”, “project”, “could”, “plan”, “intend”, “should”, “believe”, “outlook”, “potential”, “target” and similar words suggesting future events or future performance. In particular, but without limiting the generality of the foregoing, this news release includes forward-looking statements including that a special dividend will be paid to shareholders on October 25, 2024 to shareholders of record on October 11, 2024; plans for drilling two remaining wells in its southeast Alberta Atlee Buffalo F and G pools with drilling operations expected to be finished early in the fourth quarter with wells brought on production as they are tied-in through the remainder of the year; and management’s expectation that it could take until mid-2025 to increase reservoir pressure and evaluate production response at three producers at its new pilot EOR project in Marsden, Saskatchewan.

Forward‐looking statements are based on a number of material factors, expectations or assumptions of Hemisphere which have been used to develop such statements and information, but which may prove to be incorrect. Although Hemisphere believes that the expectations reflected in such forward‐looking statements or information are reasonable, undue reliance should not be placed on forward‐looking statements because Hemisphere can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified herein, assumptions have been made regarding, among other things: the timing for payment of the special dividend; no delays in the anticipated timing for delivery of the polymer skid and EOR project; the general continuance of current industry conditions; the timely receipt of any required regulatory approvals; the ability of Hemisphere to obtain qualified staff, equipment and services in a timely and cost efficient manner; drilling results; the ability of the operator of the projects in which Hemisphere has an interest in to operate the field in a safe, efficient and effective manner; the ability of Hemisphere to obtain financing on acceptable terms; field production rates and decline rates; the ability to replace and expand oil and natural gas reserves through acquisition, development and exploration; the timing and cost of pipeline, storage and facility construction and expansion and the ability of Hemisphere to secure adequate product transportation; future commodity prices; currency, exchange and interest rates; regulatory framework regarding royalties, taxes and environmental matters in the jurisdictions in which Hemisphere operates; and the ability of Hemisphere to successfully market its oil and natural gas products.

The forward‐looking statements included in this news release are not guarantees of future performance and should not be unduly relied upon. Such information and statements, including the assumptions made in respect thereof, involve known and unknown risks, uncertainties and other factors that may cause actual results or events to defer materially from those anticipated in such forward‐looking statements including, without limitation: changes in project timelines and workstreams; changes in commodity prices; changes in the demand for or supply of Hemisphere’s products, the early stage of development of some of the evaluated areas and zones; unanticipated operating results or production declines; changes in tax or environmental laws, royalty rates or other regulatory matters; changes in development plans of Hemisphere or by third party operators of Hemisphere’s properties, increased debt levels or debt service requirements; inaccurate estimation of Hemisphere’s oil and gas reserve volumes; limited, unfavourable or a lack of access to capital markets; increased costs; a lack of adequate insurance coverage; the impact of competitors; and certain other risks detailed from time‐to‐time in Hemisphere’s public disclosure documents, (including, without limitation, those risks identified in this news release and in Hemisphere’s Annual Information Form).

The forward‐looking statements contained in this news release speak only as of the date of this news release, and Hemisphere does not assume any obligation to publicly update or revise any of the included forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Release – MustGrow Provides 2024 Pipeline Update

Posted on by dburczyk@noblecapitalmarkets.com

Research News and Market Data on MGROF

  • MustGrow transitions from R&D to commercialization.
  • TerraSanteTM biofertility product manufacturing and sales has commenced, with potential initial sales ramp-up in 2025 and 2026.
  • Commercialization of TerraMGTM soil biopesticide is progressing under the Bayer commercial agreement in the EU, Middle East and Africa.
  • Registration work for TerraMGTM soil biopesticide continues in the U.S. and Canada.
  • Expiration of exclusive non-commercial agreements.
  • Intellectual property portfolio continues to grow.
  • Management presentation and Q&A set for Tuesday September 24, 2024.

Saskatoon, Saskatchewan–(Newsfile Corp. – September 23, 2024) – MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to provide its 2024 pipeline update. The Company is a leader in innovative biological nutrition and crop protection solutions from mustard and today announced significant developments in the commercialization of its flagship products, TerraSanteTM and TerraMGTM, as the Company advances its efforts to transform sustainable agriculture.

TerraSanteTM: Initial Sales and Market Opportunity

MustGrow is pleased to announce that TerraSanteTM is in the initial stages of commercialization, with product registration successfully obtained in key high value crop growing U.S. states, including California, Florida, Arizona, Idaho, Oregon, and Washington. The Company is receiving purchase orders and sales have commenced, marking a major milestone for the Company.

To assist in executing the direct sales and marketing strategy in the U.S., MustGrow engaged the services of two key industry veterans, Tim Lichatowich and Mike Atkins, who have close to six decades of combined experience in the fruit, vegetable and row crop markets.

“We are seeing strong initial interest in TerraSanteTM, particularly in California, where the market demand for a product like MustGrow’s is significant,” said Mike Atkins. Tim Lichatowich, who led multiple grower and industry meetings in California throughout 2024 also commented, “The potential for TerraSanteTM is even greater than we anticipated, with opportunity for multiple applications per year over large acreages.”

Key highlights of TerraSanteTM‘s market progress include:

  • Initial Sales: Sales have commenced in the U.S., following registrations in several key fruit & vegetable growing states.
  • Potential Market Opportunity: To date, MustGrow’s representatives are in direct contact with production companies covering an estimated 355,000 acres. These acres support multiple crops per year, therefore, there is potential for multiple applications of TerraSanteTM annually. Sales volume from multiple applications is beyond what was initially anticipated, and as such, the 355,000 acres could potentially translate into 850,000 to 1 million acres per year application potential. This is just on a small fraction of the estimated 5.6 million acres of high value crops in the US (fruit & vegetable; tree, nut & vine; root & tuber).
  • Potential Future Growth: For 2024 and 2025, initial sales and successful customer testing results will drive sales growth. Commercial sales and data on product performance is expected during the upcoming winter and spring. From there, management anticipates a full-scale sales ramp-up in 2025 and 2026.

TerraSanteTM Production Update

Manufacture of TerraSanteTM started in 2023 with MustGrow’s first commercial production run. MustGrow is actively planning for larger-scale production to meet anticipated demand. The Company is exploring various production options, including existing and expanded contract manufacturing partnerships.

“This is a very exciting time for MustGrow with actual production and sales,” said Corey Giasson, MustGrow’s President & CEO. “A few years ago, I mentioned that MustGrow was going to start the commercialization process. Well we did, and what you are witnessing is the transformation of the Company from being strictly an R&D company to now one with product sales. Our goal with TerraSanteTM, and other future registered products such as TerraMGTM, is to not only produce enough product to meet demand but do so in a cost-effective manner so as to increase margins and return on investment. You can be rest assured, that MustGrow’s management focuses on this each and every day.”

TerraSanteTM for Soil and Ecological Health

MustGrow’s soil amendment and biofertility development programs focus on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. Soil is a farmer’s most valuable asset, and MustGrow’s mustard plant-based technologies are being developed with the intention to improve not only the health of the soil, but also the surrounding ecological environment.

As an organic biofertilizer in wettable powder form, TerraSanteTM contains nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially improving beneficial microbial activity and ensuring long-term sustainable soil health. These targeted micro-communities have been shown to work to improve nutrient availability, which can potentially increase plant vigor and yields, while reducing plant stress. TerraSanteTM has the potential to improve crop nutrient uptake and, hence, overall crop performance. There are no artificial additives or preservatives used during its manufacturing.

TerraMGTM: Progress with Bayer

TerraMGTM‘s commercialization is progressing under MustGrow’s commercial agreement with Bayer for Europe, the Middle East, and Africa. While registrations are still in process in the US and Canada, MustGrow is encouraged by the ongoing work and progress being made alongside Bayer in the EU.

“We are very pleased with how things are proceeding with Bayer and they have been a great partner,” said MustGrow’s CEO. “Field trials are continuing in multiple countries and regions, and Bayer’s technical, regulatory, production, sales and marketing teams are providing excellent support as we work to advance TerraMGTM under the commercial agreement.”

Key developments for TerraMGTM under the Bayer commercial agreement include:

  • Signing of the Bayer Commercial Agreement: This agreement, signed in December 2023, includes licensing for Europe, the Middle East, and Africa, and included an upfront payment as well as milestone payments to MustGrow for development and registration work.
  • Field Trials and Technical Success with Bayer: Field trials and technical evaluations continue to yield positive results for both nematode and disease treatment, with the next program review scheduled for the end of October at the Annual Biocontrol Industry Meeting (“ABIM”) meeting in Basel.
  • Assessing Future Production for Bayer: MustGrow and Bayer are also focusing on sourcing raw materials and scaling production capabilities for future sales and growth.

TerraMGTM in U.S. and Canada

TerraMGTM registration work continues to progress in the U.S. with the Environmental Protection Agency (“EPA”) and in Canada with the Pest Management Regulatory Agency (“PMRA”). MustGrow continues to work closely with regulatory agencies and consultants and management remains committed to continuing these registrations.

Exclusive Non-Commercial Agreements

MustGrow is announcing expiration of the exclusive non-commercial agreements with NexusBioAg, Janssen PMP and Sumitomo Corporation. The Company collected substantial data and market analysis through these agreements and will now move forward on a non-exclusive basis with multiple parties to commercialize these opportunities.

Intellectual Property Portfolio

MustGrow continues to build its intellectual property portfolio, with 112 issued and pending patents, even as the Company pivots from R&D toward commercialization. This is up from 84 total patents issued and pending in March of 2023.

The intellectual property pipeline continues to grow through MustGrow’s own work as well as collaborations with university, government and other research groups. Expanded infield applications of existing formulations as well as new active ingredients are generating new product and patent opportunities. Most recently, the Company and Agriculture and Agri-Food Canada announced funding to explore the possibilities of MustGrow’s mustard extracts in the human and animal health area.

Future Roadmap

Looking ahead, MustGrow’s 2024-2025 roadmap focuses on delivering the commercialization of TerraSanteTM and TerraMGTM, validating product efficacy through sales, and driving global expansion. The Company is committed to fostering its partnership with Bayer and securing new commercial partners in non-commercialized territories, including Mexico, South America, and Asia.

“We are evolving as a Company, and sales, margins and return on investment will become key drivers for our growth moving forward,” said Mr. Giasson. “While blue-sky opportunities remain important, our focus will shift towards delivering on our commercial potential.”

Management Presentation and Q&A

MustGrow is pleased to invite investors and other interested parties to attend an upcoming interview with Market Radius Research. The Company’s CEO Corey Giasson and COO Colin Bletsky will be presenting an update and taking any questions for the audience. The webinar will be a live, interactive online event where attendees are invited to ask the Company questions in real-time following the interview. An archived webcast will be made available for those who cannot join the event live on the day of the webinar.

  • Event: Radius Research Pitch, Deep Dive, and Q&A with MustGrow Biologics (MGRO)
  • Presentation date & time: Tuesday, September 24th @ 4 PM ET
  • Registration link:

Market Radius Research gives individual investors access to in-depth CEO interviews with deep-dive institutional level discussion and Q&A. Market Radius is hosted by Martin Gagel, former top-ranked technology analyst. By registering for this webinar, you agree to receive email communications from Market Radius Capital, Inc. and from the presenting company (with unsubscribe). Your email will not be further shared. Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice and may own shares in mentioned companies and may be compensated for these services. Content is for information purposes only and is not advice or recommendations and may include incomplete or incorrect information. Investing entails a high degree of risk. This is a production of Market Radius Capital, Inc.

About MustGrow

MustGrow is an agriculture biotech company developing organic biocontrol and biofertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply and help farmers feed the world. The Company has a registered and organically certified biofertility product call TerraSanteTM in key U.S.-states including California. Registrations of TerraSanteTM are owned by MustGrow and production and sales of TerraSanteTM has commenced with ramp-up slated to begin in 2025 and 2026. Commercialization is also occurring under biocontrol, with Bayer signing on under a Commercial Licensing agreement in December 2023 for the TerraMGTM soil biopesticide in Europe, the Middle East and Africa. MustGrow estimates that Bayer will spend US$35-40 million for upfront and milestone payments and registration work of TerraMGTM in their respective territory. The Company’s main focus is continued commercialization globally of it products and technologies, and to expand its intellectual property portfolio from approximately 112 patents that are issued and pending. MustGrow is a public company (TSXV: MGRO) and has approximately 51.6 million basic common shares issued and outstanding and 55.7 million shares fully diluted. For further details, please visit www.mustgrow.ca.

Contact Information

Corey Giasson
Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca

MustGrow Forward-Looking Statements

Certain statements included in this news release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.

Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. Examples of forward-looking statements in this news release include, among others, statements MustGrow makes regarding: its commercialization strategy; its continuing efforts towards further state-level registrations; TerraSanteTM ability to improve beneficial microbial activity; the ability of TerraSanteTM to increase plant vigor and yields; and the ability of TerraSanteTM to improve crop nutrient uptake. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include market receptivity to investor relations activities as well as those risks described in more detail in MustGrow’s Annual Information Form for the year ended December 31, 2023 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available on SEDAR+ at www.sedarplus.ca. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.

This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.

Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.

© 2024 MustGrow Biologics Corp. All rights reserved.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224296

Lifeway Foods (LWAY) – An Acquisition Proposal from Danone

Posted on by cpereira@noblefcm.com


Tuesday, September 24, 2024

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

The Proposal. In a move long awaited by many investors, yesterday after the market closed Danone North America proposed to acquire Lifeway for $25/sh in cash, valuing the entire Company at approximately $380 million. Although the proposal is non-binding, Danone seeks to engage in discussions with the Board with a view to signing a definitive agreement rapidly. LWAY shares reacted positively, trading up nearly 16% to $24.91 on the news.

Why Now? Danone has been a significant Lifeway shareholder since 1999 and currently owns 23.4% of the outstanding equity. According to the letter sent to management, Danone’s 2025-28 Renew strategy has a strong focus on gut health, “which is driving our interest in considering the benefits of a potential combination with Lifeway.” The probiotics in kefir may help support a healthy gut.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Century Lithium Corp. (CYDVF) – Battery Grade Lithium Carbonate Produced On-Site

Posted on by cpereira@noblefcm.com


Tuesday, September 24, 2024

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Lithium carbonate production at the pilot plant. Century Lithium recently added a lithium carbonate stage at the company’s lithium extraction facility which is part of the company’s Angel Island Mine project. Previously, concentrated lithium solutions from the pilot plant were treated by Saltworks Inc. at their facility in Richmond, British Columbia to produce samples of battery grade lithium carbonate. Century Lithium is now able to do this at the pilot plant and demonstrate it has an end-to-end process to produce lithium carbonate. The pilot plant utilizes the Company’s patent-pending process for chloride leaching combined with direct lithium extraction (DLE).

Assay results. Century Lithium recently released assay results from the first lithium carbonate produced at the lithium carbonate stage at the company’s lithium extraction facility. Assays received for the initial five individual lots of lithium carbonate produced indicated purity of the lithium carbonate ranging from 98.2% to 99.2%. After addressing a mechanical issue, two additional 40-liter lots of concentrated lithium solution were treated and achieved a battery grade lithium carbonate purity level of 99.5% due to an expected reduction of impurities.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.